Source: Health Products Regulatory Authority (ZA) Publisher: Strides Pharma SA (Pty) Ltd, 106 16<sup>th</sup> Road, Building 2, Midrand
AMDERIP 10 (film-coated tablets).
AMDERIP 25 (film-coated tablets).
AMDERIP 50 (film-coated tablets).
| Pharmaceutical Form |
|---|
|
Film-coated tablet. AMDERIP 10: Round blue colored biconvex tablets debossed 1 on one side and plain on other side. AMDERIP 25: Round yellow colored biconvex tablets plain on both sides. AMDERIP 50: Round brown colored biconvex tablets plain on both sides. |
AMDERIP 10: Each film-coated tablet contains 10 mg amitriptyline hydrochloride.
Contains sugar: lactose monohydrate 10 mg.
AMDERIP 25: Each film-coated tablet contains 25 mg amitriptyline hydrochloride.
Contains sugar: lactose monohydrate 10 mg.
AMDERIP 50: Each film-coated tablet contains 50 mg amitriptyline hydrochloride.
Contains sugar: lactose monohydrate 20 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Amitriptyline |
Amitriptyline is a tricyclic antidepressant and an analgesic. It prevents the re-uptake, and hence the inactivation of noradrenaline and serotonin at nerve terminals. Reuptake prevention of these monoamine neurotransmitters potentiate their action in the brain. This appears to be associated with the antidepressant activity. |
| List of Excipients |
|---|
|
Tablet core: Colloidal silicon dioxide Tablet coating AMDERIP 10: Hypromellose Tablet coating AMDERIP 25: Hypromellose Tablet coating AMDERIP 50: Hypromellose |
AMDERIP 10 are packed in PVC/PVdC/Aluminium blisters containing 30 film-coated tablets. The blister strips are packed in a printed carton.
AMDERIP 25 are packed in PVC/PVdC/Aluminium blisters containing 30 or 60 film-coated tablets. The blister strips are packed in a printed carton.
AMDERIP 50 are packed in PVC/PVdC/Aluminium blisters containing 30 film-coated tablets. The blister strips are packed in a printed carton.
Not all pack sizes may be marketed.
Strides Pharma SA (Pty) Ltd, 106 16th Road, Building 2, Midrand
AMDERIP 10: 54/1.2/0684.681
AMDERIP 25: 54/1.2/0685.682
AMDERIP 50: 54/1.2/0686.683
29 March 2022
| Drug | Countries | |
|---|---|---|
| AMDERIP | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
